1/I'm excited that Dr. @AjayManhapra is presenting on concerns about mandatory opioid taper for VA's MAT-VA journal club, based on our shared paper... he notes Human costs of mandatory and widespread opioid taper
2/He cites @BethDarnall as the best available study, noting that even when one offers the best support system, a significant % of patients do not have a reduction in pain or pain worsens.
3/In a way that will seem controversial, he proposes that opioid therapy is not exactly an analgesic. This is daily use of an addictive substance that offers relief, where only a minority develop addiction.
4/I should caution that @AjayManhapra is far from a "fan" of opioids for pain. Many people on them do not get benefit, he says. My reading of same data is more favorably disposed, even though we collaborate
5/There is an "opponent effect" so that relief from opioids is also opposed - not in all people and to the same degree - but this is part of the dependence dilemma for some persons at high dose
6/Trigger warning: Dr. Manhapra describes a distinct category of Opioid Use Disorder (which most patients do not have at all) from what he and some others call Complex Persistent Opioid Dependence
6/Opioid tapering is intuitively appealing but the goals of a taper are rarely declared and when they are (see below) they are not regularly achieved
7/The available data on opioid taper suggests (with low confidence) improvement if patients are in "intensive multimodal pain interventions".

And "none of these (tapering) studies showed functional improvement" says @AjayManhapra
8/As Dr. Manhapra summarizes, regarding opioid taper

"There is no clear benefit but there are reports of harm"
9/Dose and risk of harm are correlated, but it's complicated. "It's not the opioids alone" - the risk is determined by what else is going on in their lives, personal characteristics. Dose is a MINOR factor in the modeled risk in Veterans Administration
10/Most overdose happens at low dose- so focus on dose is not solid. Veterans Affairs overdose data.
11/Even with heroin/fentanyl, the deaths are polypharmacy often with LOW dose of heroin!
12/Opioid cessation associated with increased risk of overdose/suicide in Veterans. It's highest in the first month afterward. Then begins to fall. But it never comes down to the level of the persons who were continued on opioids. bmj.com/content/368/bm…
13/Also all cause mortality was elevated after long term opioid therapy interruption in a VA HIV cohort (VACS). Note Dr. Manhapra (like me) is pointing out a fact pattern and NOT arguing every death is Cause and Effect. Humility is called for
14/In pursuing this discussion I want to highlight issues that we understand are subject to immense dispute because the underlying data are themselves either do not exist or are quite poor
15/If a patient is stable and ostensibly at a higher level of risk for adverse effects from opioids they receive, would reduction of dose make them safer, if they *consented for that personally*? We are aware of *no evidence* although I think it's totally reasonable to discuss
16/If a patient has shown higher-risk problems (like turning up drunk in the ER while also having taken the prescribed opioids, i.e. major overdose risk), do the clinicians make the patient *safer* by switching to buprenorphine as a "safer opioid". FYI: this comes up a lot
17/Please note that honest discussion here has a few limitations. First my friends and I (who discuss these matters with in good faith) often do NOT agree. I am still wrestling with what it would mean to adopt concepts put forward by my friend Ajay. He knows that!
18/Sadly, there are also bad-faith discussants who have slung arrows. Usually, from folks who:

*don't have frontline primary care experience
*don't propose, fund and deliver peer-reviewed research
*are paid by law firms
*discount experiences of people with lived experience
19/The story should be about the people and the families whose care has been upended in part because of poor science, immodesty, and policymakers addiction to "quick fixes"

#Listen (YES: after 19 tweets in a row, that applies to me too)

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Stefan Kertesz, MD

Stefan Kertesz, MD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @StefanKertesz

8 Jan
1/Nice viewpoint out today: "Balancing the Risks and Benefits of Benzodiazepines" -authors note risks of these drugs and their utility, in light of @US_FDA changing the label to highlight risks jamanetwork.com/journals/jama/…
2/FDA's revised warning will more thoroughly cover risks, and the authors endorse that "increased caution regarding benzodiazepine use is warranted; fewer benzodiazepine prescriptions are needed" ... with a careful stipulation...
3/Benzodiazepine risks needed to be highlighted, "However, when considered without an appropriate patient-centered context, this enhanced warning statement might lead to fewer appropriate prescriptions and unintended consequences" - this should echo what happened with opioids
Read 9 tweets
3 Jan
1/FYI:Opioid Rx’s ⬇️ 60% vs 9 years ago.

Outcomes have not been good. OD deaths are way ⬆️, & patients traumatized

This thread covers 4 years of my peer-reviewed articles.

Let’s recalibrate policy, measure what we are doing, and LISTEN to the folks whose lives are at stake
2/This is the overall policy review of how we got here and how we mis-allocated the response (with @AJ_Gordon) ,

and why policy winds up (inevitably) being less than rational in the real world @AddictionJrnl onlinelibrary.wiley.com/doi/abs/10.111…
3/This piece says why efforts to “Turn the Tide” with a narrow focus on Rx risked a Riptide for patients, as fentanyl deaths rose.

The article led me to brief then Surgeon General @vivek_murthy in 2017- who shared this concern completely tandfonline.com/doi/full/10.10…
Read 12 tweets
31 Dec 20
“Why did so many physicians become Nazis?” – this new essay bears on us, the non-Nazi doctors. In short, “science” can be invoked by immoral agents, & science language can seduce us into societal plans that override our duties to individuals @tabletmag /1 tabletmag.com/sections/histo…
Germany was extreme, of course.

Over 50% of doctors joined the Nazi party. There, Jews, gays & disabled persons were designated a disease on the German “body”. Ridding Germany of them was seen as good science.

We need not project the US will follow that, ever /2
But the US & other nations have not been alien to an immoral use of science-based authority.

Germany’s Laws for the Prevention of Genetically Diseased Offspring were based on American laws, passed earlier. We should all know about Tuskegee
/3 cdc.gov/tuskegee/timel…
Read 15 tweets
15 Dec 20
1/This week in @journaljgim: “Promoting Patient-Centeredness in #opioid Deprescribing: a Blueprint for De-implementation Science”

Tools of “deimplementation science” should guide evaluation of health care changes - w/@BethDarnall @AllysonVarley
link.springer.com/article/10.100…
2/Opioid prescribing has ⬇️37% since its peak in 2011. Today, many agencies agree that “deprescribing” was not carried out in ways that consistently protected patients.

We ask “how can well-intended changes to care transpire in ways that are unsafe or harmful?” 2019 CDC Surveillance Report, IQVIA data
3/De-implementation= “reducing or stopping practices that are ineffective, unproven, harmful, overused, or inappropriate”
With opioids, that could be not starting, stopping or reducing.For us, this does *not* reflect a commitment to opioid elimination from care.h/t @VPrasadMDMPH
Read 15 tweets
11 Dec 20
We are eager to hear the plenary speaker for @US_ASP (the new academic pain org for the US) Dr. Meghani of U.Penn Nursing.. on the "Guideline Epidemic and Pain Care" introduced by @JessicaMerlinMD @DrJohnPereira /1
Key points for Dr. Meghani:
*US fighting its drug war "like other resource poor countries"
*Broad misapplication of the 2016
@CDCgov
opioid guideline
*Seriously undermined care of patients with mod to severe pain
*Obligations of policy makers in scaling high policies /2
Key points made by Dr. Meghani, of U Penn Nursing for
@US_ASP
Insurers and states acted rapidly, in 2016-17 after
@CDCgov
, to impose hard #opioid dose limits, to require opioid stoppage and taper, all in apparent violation of the Guideline, which had a low evidence GRADE /3
Read 5 tweets
10 Dec 20
1/Bravo to Dr. @BethDarnall for stating (and better, helping lead a trial) ethical principles of a taper in which the patient is the agent, it's voluntary, and dose might go UP too. Thank-you @OldHeadFighta for the image in the next Tweet that captures the ethics here
2/Yes yes @OldHeadFighta - this gets at the reality that the principle is here is not just clinical but ETHICAL (and then I'll get to ethics)
3/The obligation upon clinicians is to treat the people in our care as full-fledged. Don't treat patients as means to an end, we wrote. Mandated dose reductions of opioids are "Not Justifiable Clinically or Ethically": pubmed.ncbi.nlm.nih.gov/32631183/
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!